Compounds > arsenic
Page last updated: 2024-08-26

arsenic and sulindac

arsenic has been researched along with sulindac in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, SL; Jiang, TT; Kim, JH1
Jeong, ET; Kim, EJ; Kim, HR; Kim, SJ; Park, C; Park, R; So, HS; Yang, SH; Youn, MJ1
An, S; Choe, TB; Hong, SI; Jin, HO; Kim, JI; Kwon, TJ; Lee, HC; Lee, SJ; Park, IC; Park, MJ; Rhee, CH; Seo, SK; Woo, SH; Yoo, DH; Yoon, SI1
An, S; Choe, TB; Hong, SI; Jin, HO; Kim, ES; Kim, JI; Lee, HC; Lee, SJ; Park, IC; Rhee, CH; Seo, SK; Woo, SH; Yoo, DH1
Cheong, HJ; Kim, SJ; Lee, HR; Lee, NS; Park, HS; Won, JH1
Jang, HY; Jeong, ET; Jo, HJ; Kim, EJ; Kim, HJ; Kim, HR; Lee, KK; Park, JH; Shim, H; Yang, SH1
Arkusz, J; Ferlińska, M; Gradecka-Meesters, D; Smok-Pieniążek, A; Stańczyk, M; Stępnik, M2

Other Studies

8 other study(ies) available for arsenic and sulindac

ArticleYear
Combined effect of arsenic trioxide and sulindac sulfide in A549 human lung cancer cells in vitro.
    Journal of experimental & clinical cancer research : CR, 2004, Volume: 23, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Humans; In Vitro Techniques; Lung Neoplasms; Oxides; Sulindac; Tumor Cells, Cultured; Tumor Stem Cell Assay

2004
Combination treatment with arsenic trioxide and sulindac augments their apoptotic potential in lung cancer cells through activation of caspase cascade and mitochondrial dysfunction.
    International journal of oncology, 2006, Volume: 28, Issue:6

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Flow Cytometry; Growth Inhibitors; Humans; Hydrogen Peroxide; Lung Neoplasms; Oxides; Sulindac

2006
Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
    Biochemical pharmacology, 2006, Nov-15, Volume: 72, Issue:10

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Synergism; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Microtubule-Associated Proteins; Neoplasm Proteins; Oxides; Reactive Oxygen Species; Sulindac; Survivin

2006
A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation.
    Lung cancer (Amsterdam, Netherlands), 2008, Volume: 61, Issue:3

    Topics: Acetylcysteine; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Drug Synergism; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Oxides; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Sulindac

2008
Sulindac enhances arsenic trioxide-mediated apoptosis by inhibition of NF-kappaB in HCT116 colon cancer cells.
    Oncology reports, 2008, Volume: 20, Issue:1

    Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspase 8; Cell Proliferation; Drug Synergism; HCT116 Cells; Humans; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Oxides; Phosphorylation; Sulindac

2008
Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases.
    Oncology reports, 2008, Volume: 20, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; DNA Damage; Enzyme Inhibitors; Flow Cytometry; G1 Phase; Heme Oxygenase-1; Histones; Humans; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Oxidative Stress; Oxides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Sulindac; Tumor Cells, Cultured

2008
Sulindac and its metabolites: sulindac sulfide and sulindac sulfone enhance cytotoxic effects of arsenic trioxide on leukemic cell lines.
    Toxicology in vitro : an international journal published in association with BIBRA, 2011, Volume: 25, Issue:5

    Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Drug Synergism; Flow Cytometry; HL-60 Cells; Humans; Jurkat Cells; K562 Cells; Lymphocytes; Membrane Potential, Mitochondrial; Mice; NF-kappa B; Oxides; Propidium; Staining and Labeling; Sulindac

2011
Assessment of the involvement of oxidative stress and Mitogen-Activated Protein Kinase signaling pathways in the cytotoxic effects of arsenic trioxide and its combination with sulindac or its metabolites: sulindac sulfide and sulindac sulfone on human leu
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Glutathione; Humans; Leukemia; Mitogen-Activated Protein Kinases; Oxidative Stress; Oxides; Reactive Oxygen Species; Signal Transduction; Sulindac

2012